Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Int J Hyperthermia. 2017 May 11;34(1):87–100. doi: 10.1080/02656736.2017.1319077

Figure 3.

Figure 3

USAFs as a function of the HT treatment frequency for tumours #1 through #12. The red numbers indicates, for each tumour location, the ratio of the highest to the lowest uSAF. In other words, this ratio indicates the expected improvement in SAF treatment efficacy by optimising the treatment frequency.